Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celnovte Biotechnology provides market-leading automated instruments and reagents for immunohistochemistry, in situ hybridization, cytology, histology staining, digital slide scanning, with proprietary technologies such as MicroStacker™. Their products are widely adopted across China’s top hospitals and over forty countries worldwide. They have received international quality certifications including ISO9001/ISO13485/NMPA Class III/CE-IVD.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celnovte Biotechnology.